surmount-1 trial tirzepatide obesity without diabetes once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide for Obesity Treatment and

In most cases, GLP-1 injections are administered once a week

Disrupting a protocol due to avoidable injection discomfort means losing the cumulative biological benefit that consistent administration was building toward

Among the targets of p53 activity are sestrins (sestrin 1 and 2) that induce the activity of peroxiredoxins, increasing the impact of the cellular antioxidant array 26

Polyethylene glycol (PEG) or poly(lactide-co-glycolide) (PLGA) are a commonly used coating agent in nanomedicine ( 2-x Se ( 2.2 Morphological issues in nanoparticle systems for GBM Size and surface characteristics as size, shape, porosity, charge are critical factors influencing the NPs drug delivery effectiveness

Efficacy and safety of exenatide once weekly versus liraglutide in subjects with type 2 diabetes (DURATION-6): a randomised, open-label study [abstract 75]

Back Dunleavy, K (22 Nov 2023) 'To address shortage, Novo Nordisk will cut production of Victoza to boost supply of Ozempic', Fierce Pharma